Supercharging Immunotherapy

fancy black and blue t-cell 3d scientific images immune system

To reprogram the immune system to help overcome cancer and infectious diseases. We do this by using a technology that “supercharges” the natural ability of the immune system to combat disease.

2 Jul 2018

Dr. Lengauer has an outstanding track-record in cancer drug discovery,...

18 Jun 2018

Hookipa and Gilead will jointly develop therapeutics against HIV and Hepatitis...

15 May 2018

TheraT®-induced CD8+ T cells are resistant to select checkpoint inhibitors,...

all news

12 - 14 Nov 2018

Shanghai, China

28 - 30 Nov 2018

San Diego, USA

all events

The source of Hookipa’s strength lies in our people. We value individuals and human rights. We value teamwork. We value diversity - gender, race, nationality, character. We value respect. We want to continue to grow fast as a company and develop as individuals. Get in touch to know more about our career opportunities!

Supercharging Immunotherapy

Our Mission

News

Hookipa Appoints Dr. Christoph Lengauer to its Board of Directors as a...

Hookipa and Gilead Enter into a Collaboration and License Agreement to Develop...

New Insights into Hookipa’s TheraT® Replicating Viral Vector Platform...

Our Pipeline

Events

China Healthcare Summit

World Vaccine & Immunotherapy Congress West Coast 2018

Careers